Abstract
Transplantation between red cell-disparate donor and recipient is feasible with minimal increase in the risk of transplantation if consideration is given to the immunohematological consequences of the transplant. The risks of immediate and delayed hemolysis must be managed. Some recipients will experience a delay in the recovery of red blood cells. Bone Marrow Transplantation (2001) 28, 315–321.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gale RP, Feig S, Ho W et al. ABO blood group system and bone marrow transplantation Blood 1977 50: 185–194
Buckner CD, Clift RA, Sanders JE et al. ABO-incompatible marrow transplants Transplantation 1978 26: 233–238
Tippett P . Chromosome mapping of the blood group genes Semin Hematol 1981 18: 4–12
Franchini M, de Gironcoli M, Gandini G et al. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT Bone Marrow Transplant 1998 21: 1071–1073
Leo A, Mytilineos J, Voso MT et al. Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jka after allogeneic PBPC transplantation Transfusion 2000 40: 632–636
Dinsmore RE, Reich LM, Kapoor N et al. ABH incompatible bone marrow transplantation: removal of erythrocytes by starch sedimentation Br J Haematol 1983 54: 441–449
Braine HG, Sensenbrenner LL, Wright SK et al. Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion Blood 1982 60: 420–425
Sniecinski IJ, O'Donnell MR . Hemolytic complications of hematopoietic cell transplantation In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic Cell Transplantation Blackwell Science: Malden 1999 pp 674–684
Marmont AM, Damasio EE, Bacigalupo A et al. A to O bone marrow transplantation in severe aplastic anaemia: dynamics of blood group conversion and demonstration of early dyserythropoiesis in the engrafted marrow Br J Haematol 1977 36: 511–518
Gmur JP, Burger, J, Schaffner A et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation Blood 1990 75: 290–295
Worel N, Greinix HT, Schneider B et al. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems Transfusion 2000 40: 543–550
Benjamin RJ, Connors JM, McGurk S et al. Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia Biol Blood Marrow Transplant 1998 4: 151–156
Bar BMAM, Van Dijk BA, Schattenberg A et al. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow Bone Marrow Transplant 1995 16: 793–799
Hows J, Beddow K, Gordon-Smith E et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation Blood 1986 67: 177–181
Gajewski JL, Petz LD, Calhoun L et al. Hemolysis of transfusion group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate Blood 1992 79: 3076–3085
Greeno EW, Perry EH, Ilstrup SJ, Weisdorf DJ . Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility Transfusion 1996 36: 71–74
Toren A, Dacosta Y, Manny N et al. Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation Blood 1996 87: 843–844
Bornhauser M, Ordemann R, Paaz U et al. Rapid engraftment after allogeneic ABO-incompatible peripheral blood stem cell transplantation complicated by severe hemolysis Bone Marrow Transplant 1997 19: 295–297
Laurencet FM, Samii K, Bressoud A et al. Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility Hematol Cell Ther 1997 39: 159–162
Oziel-Taieb S, Faucher-Barbey C, Chabannon C et al. Early and fatal immune haemolysis after so-called ‘minor’ ABO-incompatible peripheral blood stem cell allotransplantation Bone Marrow Transplant 1997 19: 1155–1156
Salmon JP, Michaux S, Hermanne JP et al. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation Transfusion 1999 39: 824–827
Rowley SD, Liang PS, Ulz L . Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components Bone Marrow Transplant 2000 26: 749–757
Benjamin RJ, McGurk S, Ralson MS, Churchill WH, Antin JH . ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation Transfusion 1999 39: 179–187
Benjamin RJ, Antin JH . ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity Transfusion 1999 39: 1273–1274
Webb IJ, Soiffer RJ, Anderson JW et al. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation Biol Blood Marrow Transplant 1997 3: 267–272
Standards for Blood Banks and Transfusion Services 18th edn American Association of Blood Banks: Bethesda, MD 1997
Rodriquez JM, Carmona M, Noguerol P et al. A fully automated method for mononuclear bone marrow cell concentration J Clin Apheresis 1992 7: 101–109
Davis JM, Schepers KG, Eby LL, Noga SJ . Comparison of progenitor cell concentration techniques: continuous flow separation versus density-gradient isolation J Hematother 1993 2: 315–320
Zingsem J, Zeiler T, Zimmermann R et al. Bone marrow processing with the Fresenius AS 104: initial results J Hematother 1992 1: 273–278
Dinsmore RE, Reich LM, Kapoor N et al. ABH incompatible bone marrow transplantation: removal of erythrocytes by starch sedimentation Br J Haematol 1983 54: 441–449
Sierra J, Storer B, Hansen JA et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose Blood 1997 89: 4226–4235
Warkentin PI, Yomtovian R, Hurd D et al. Severe delayed hemolytic transfusion reaction complicating an ABO-incompatible bone marrow transplantation Vox Sang 1983 45: 40–47
Karhi KK, Andersson LC, Vuopio P, Bahmberg CG . Expression of blood group A antigens in human bone marrow cells Blood 1981 57: 147–151
Lopez A, de la Rubia J, Arriaga F et al. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant Transfusion 1998 38: 247–251
Sniecinski IJ, Oien L, Petz LD, Blume KG . Immunohematologic consequences of major ABO-mismatched bone marrow transplantation Transplantation 1988 45: 530–534
Mielcarek M, Leisenring W, Torok-Storb B, Storb R . Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect Blood 2000 96: 1150–1156
Santamaria A, Sureda A, Martino R et al. successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin Bone Marrow Transplant 1997 20: 1105–1107
Ohashi K, Akiyama H, Takamoto S et al. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin Bone Marrow Transplant 1994 13: 335–336
Labar B, Bogdanic V, Memet D et al. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant Bone Marrow Transplant 1992 10: 471–472
Selleri C, Raiola A, De Rosa G et al. CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation Bone Marrow Transplant 1998 22: 605–607
Hazelhurst GR, Brenner MK, Wimperis JZ et al. Hemolysis after T-cell depleted bone marrow transplantation involving minor ABO incompatibility Scand J Haematol 1986 37: 1–3
Rosental GJ, Weigand GW, Germolec DR et al. Suppression of B cell function by methotrexate and trimetrexate – evidence for inhibition of purine biosynthesis as a major mechanism of action J Immunol 1988 141: 410–416
Acknowledgements
The author wishes to thank Laura Ulz, RN and the staff of the Transfusion Service of the Fred Hutchinson Cancer Research Center, Seattle, WA for their expert help in developing the algorithms of support described in this manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rowley, S. Hematopoietic stem cell transplantation between red cell incompatible donor–recipient pairs. Bone Marrow Transplant 28, 315–321 (2001). https://doi.org/10.1038/sj.bmt.1703135
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703135
Keywords
This article is cited by
-
Kinetics of disappearance and appearance of isoagglutinins A and B after ABO-incompatible hematopoietic stem cell transplantation
Bone Marrow Transplantation (2022)
-
Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplants
Annals of Hematology (2021)
-
Immune-mediated cytopenia in pediatric primary immune deficiency patients following HSCT
Bone Marrow Transplantation (2017)
-
Major ABO incompatible BMT in children: determining what residual volume of donor red cells can safely be infused following red cell depletion
Bone Marrow Transplantation (2015)
-
Essential requirements for setting up a stem cell processing laboratory
Bone Marrow Transplantation (2014)